首页 > 最新文献

Journal of Blood Medicine最新文献

英文 中文
Telomere Dynamics in Sickle Cell Anemia: Unraveling Molecular Aging and Disease Progression 镰状细胞性贫血的端粒动力学:揭示分子老化与疾病进展
Pub Date : 2024-07-01 DOI: 10.2147/jbm.s462758
E. Obeagu, G. Obeagu
{"title":"Telomere Dynamics in Sickle Cell Anemia: Unraveling Molecular Aging and Disease Progression","authors":"E. Obeagu, G. Obeagu","doi":"10.2147/jbm.s462758","DOIUrl":"https://doi.org/10.2147/jbm.s462758","url":null,"abstract":"","PeriodicalId":506923,"journal":{"name":"Journal of Blood Medicine","volume":"63 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141842079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of Novel Hb Guiyang [HBA2: c.151C > A α2 50 (CE8) His- Asn] and Phenotype- Genotype Correlation of Abnormal Hemoglobins in Guizhou, Southwest China 中国西南地区新型贵阳血红蛋白[HBA2: c.151C > A α2 50 (CE8) His- Asn]的鉴定及异常血红蛋白的表型-基因型相关性研究
Pub Date : 2024-06-01 DOI: 10.2147/jbm.s458057
Ya-Ping Chen, Heng Wang, Lei Wang, Dan Xie, Min Guo, Jiang-Fen Wu, Bang-Quan An, Sheng-Wen Huang
{"title":"Identification of Novel Hb Guiyang [HBA2: c.151C > A α2 50 (CE8) His- Asn] and Phenotype- Genotype Correlation of Abnormal Hemoglobins in Guizhou, Southwest China","authors":"Ya-Ping Chen, Heng Wang, Lei Wang, Dan Xie, Min Guo, Jiang-Fen Wu, Bang-Quan An, Sheng-Wen Huang","doi":"10.2147/jbm.s458057","DOIUrl":"https://doi.org/10.2147/jbm.s458057","url":null,"abstract":"","PeriodicalId":506923,"journal":{"name":"Journal of Blood Medicine","volume":"55 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141404472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hematological Abnormalities and Associated Factors Among Patients with Hypothyroidism at the University of Gondar Comprehensive Specialized Hospital 贡德尔大学综合专科医院甲状腺功能减退症患者的血液异常及其相关因素
Pub Date : 2024-03-01 DOI: 10.2147/jbm.s453015
D. Berta, Yemataw Gelaw, E. Shiferaw, Abateneh Melkamu, Gebrehiwot Legese, Tiruneh Adane, Befikad Mandefro
Objective: Abnormalities in blood cells are frequently associated with thyroid hormone disorders as a result of their involvement in the proliferation and production of blood cells. This study aimed to determine the magnitude and associated factors of hematological abnormalities in patients with hypothyroidism. Methods: A cross-sectional study was conducted from January 1 to June 30, 2023, at the University of Gondar Comprehensive Specialized Hospital. The present study included a total of 300 patients with hypothyroidism prospectively using the systematic random sampling technique. The hematological parameter data were collected using data extraction sheets, whereas the associated factor data were collected using both structured questionnaires and data extraction sheets. For complete blood cell counts, 4 mL of anticoagulated venous blood was collected and analyzed. The data were entered into Epi-data version 3.1 and analyzed with Stata version 14. Both bivariate and multivariate logistic regressions were performed to identify factors associated with hematological abnormalities. A P value < 0.05 was considered to indicate statistical significance. Results: The median value of red blood cell, hemoglobin, mean cell volume, white blood cell, and platelet were 4.63 x10 12 /µL, 14 g/ dL, 84.3fl, 5.3 x10 3 /µL, and 228, respectively. The overall incidences of anemia, leucopoenia, and thrombocytopenia in patients with hypothyroidism were 26.3% (95% confidence interval (CI): 21–32), 15.7% (95% CI: 14.2–17.2), and 9% (95% CI: 7.5–10.5), respectively. Lymphopenia was detected in 9% (95% CI: 8.6–10.1) of the patients, and neutropenia was detected in 6% (95% CI: 4.4–7.6) of the patients. Only three factors, female sex (adjusted odds ratio (AOR) =2.1, 95% CI=1.3–3.1), alcohol consumption (AOR= 3.8, CI=1.7–8.9), and febrile illness (AOR=2.7, 95% CI=1.3–5.4), were found to be significantly associated factors for anemia. Conclusion: The present study revealed heterogeneous hematological abnormalities in patients with hypothyroidism. Thus, early diagnosis and monitoring strategies are required to minimize complications in patients.
目的血细胞异常经常与甲状腺激素紊乱有关,因为它们参与了血细胞的增殖和生成。本研究旨在确定甲状腺功能减退症患者血液异常的程度和相关因素。研究方法于 2023 年 1 月 1 日至 6 月 30 日在贡德尔大学综合专科医院进行了一项横断面研究。本研究采用系统随机抽样技术,前瞻性地纳入了 300 名甲状腺功能减退症患者。血液参数数据通过数据提取表收集,而相关因素数据则通过结构化问卷和数据提取表收集。为了进行全血细胞计数,采集并分析了 4 毫升抗凝静脉血。数据输入 Epi-data 3.1 版,并用 Stata 14 版进行分析。进行二元和多元逻辑回归,以确定与血液异常相关的因素。P值小于0.05表示统计学意义显著。结果红细胞、血红蛋白、平均细胞体积、白细胞和血小板的中位值分别为 4.63 x10 12 /µL、14 g/dL、84.3fl、5.3 x10 3 /µL、228。甲状腺功能减退症患者贫血、白细胞减少和血小板减少的总发生率分别为 26.3%(95% 置信区间(CI):21-32)、15.7%(95% CI:14.2-17.2)和 9%(95% CI:7.5-10.5)。9%(95% CI:8.6-10.1)的患者出现淋巴细胞减少症,6%(95% CI:4.4-7.6)的患者出现中性粒细胞减少症。研究发现,只有女性性别(调整后几率比(AOR)=2.1,95% CI=1.3-3.1)、饮酒(AOR=3.8,CI=1.7-8.9)和发热性疾病(AOR=2.7,95% CI=1.3-5.4)这三个因素与贫血显著相关。结论本研究揭示了甲状腺功能减退症患者血液异常的异质性。因此,需要采取早期诊断和监测策略,以尽量减少患者的并发症。
{"title":"Hematological Abnormalities and Associated Factors Among Patients with Hypothyroidism at the University of Gondar Comprehensive Specialized Hospital","authors":"D. Berta, Yemataw Gelaw, E. Shiferaw, Abateneh Melkamu, Gebrehiwot Legese, Tiruneh Adane, Befikad Mandefro","doi":"10.2147/jbm.s453015","DOIUrl":"https://doi.org/10.2147/jbm.s453015","url":null,"abstract":"Objective: Abnormalities in blood cells are frequently associated with thyroid hormone disorders as a result of their involvement in the proliferation and production of blood cells. This study aimed to determine the magnitude and associated factors of hematological abnormalities in patients with hypothyroidism. Methods: A cross-sectional study was conducted from January 1 to June 30, 2023, at the University of Gondar Comprehensive Specialized Hospital. The present study included a total of 300 patients with hypothyroidism prospectively using the systematic random sampling technique. The hematological parameter data were collected using data extraction sheets, whereas the associated factor data were collected using both structured questionnaires and data extraction sheets. For complete blood cell counts, 4 mL of anticoagulated venous blood was collected and analyzed. The data were entered into Epi-data version 3.1 and analyzed with Stata version 14. Both bivariate and multivariate logistic regressions were performed to identify factors associated with hematological abnormalities. A P value < 0.05 was considered to indicate statistical significance. Results: The median value of red blood cell, hemoglobin, mean cell volume, white blood cell, and platelet were 4.63 x10 12 /µL, 14 g/ dL, 84.3fl, 5.3 x10 3 /µL, and 228, respectively. The overall incidences of anemia, leucopoenia, and thrombocytopenia in patients with hypothyroidism were 26.3% (95% confidence interval (CI): 21–32), 15.7% (95% CI: 14.2–17.2), and 9% (95% CI: 7.5–10.5), respectively. Lymphopenia was detected in 9% (95% CI: 8.6–10.1) of the patients, and neutropenia was detected in 6% (95% CI: 4.4–7.6) of the patients. Only three factors, female sex (adjusted odds ratio (AOR) =2.1, 95% CI=1.3–3.1), alcohol consumption (AOR= 3.8, CI=1.7–8.9), and febrile illness (AOR=2.7, 95% CI=1.3–5.4), were found to be significantly associated factors for anemia. Conclusion: The present study revealed heterogeneous hematological abnormalities in patients with hypothyroidism. Thus, early diagnosis and monitoring strategies are required to minimize complications in patients.","PeriodicalId":506923,"journal":{"name":"Journal of Blood Medicine","volume":"420 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140275073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immuno-Hematological and Biochemical Changes in Patients with Tuberculosis in Dessie Comprehensive Specialized Hospital, Dessie, Ethiopia 埃塞俄比亚德西综合专科医院结核病患者的免疫血液学和生化变化
Pub Date : 2024-03-01 DOI: 10.2147/jbm.s445857
Angesom Gebreweld, Temesgen Fiseha, E. Kebede, Zemenu Tamir, Brhane Gebremariam, Fikadu Miruts, Haftay Haileslasie
Background: Tuberculosis (TB) is a serious worldwide health issue, particularly in developing nations like Ethiopia. Patients with tuberculosis experience a range of hematological, immunological, and biochemical alterations. The purpose of this study was to evaluate immunological, hematological, and biochemical alterations of newly diagnosed TB patients at Dessie comprehensive specialized hospital, Dessie, Ethiopia. Methods: A comparative, cross-sectional study was carried out to evaluate the immuno-hematological and biochemical changes in patients with tuberculosis at Dessie comprehensive specialized hospital from January to July 2018. One hundred sixty-four (164) newly diagnosed TB patients, and 80 apparently healthy controls were included consecutively. The variables were expressed in frequency, percentage, and mean ± SD. To compare mean ± SD of the groups or within the groups, we used an independent sample t -test. Statistical significance was defined as a P value less than 0.05. Results: Male TB patients had significantly high mean absolute WBC count, neutrophil count, lymphocyte, platelet count, and systemic immune-inflammation compared with male healthy controls (P=0.001, P=0.011 P=0.021, P=0.001, and P=0.018, respectively). The mean platelet count of female TB patients was significantly higher than that of the female control group (P=0.015). However, mean RBC counts, Hgb, HCT, and MPV of TB patients were significantly lower than those of male (p<0.001) and female healthy controls (P=0.022, 0.015, and 0.001, respectively). The TB patients had developed anemia (23.8%), WBC abnormalities (29.3%), thrombocytosis (11.6%), and thrombocytopenia (9.8%). The cases had significantly higher mean alanine amino transferase, total bilirubin, and glucose level, but the mean total protein, alkaline phosphatase, and total cholesterol of cases were significantly lower than healthy control groups. Conclusion: TB patients in this study showed significant alterations in a number of hematological and biochemical profiles. This indicates that hematological and biochemical profiles should be monitored and properly interpreted for the differential diagnosis of tuberculosis and evaluation of response to treatment.
背景:结核病(TB)是一个严重的世界性健康问题,尤其是在埃塞俄比亚这样的发展中国家。结核病患者会出现一系列血液学、免疫学和生化改变。本研究旨在评估埃塞俄比亚德西综合专科医院新诊断出的肺结核患者的免疫学、血液学和生化改变。研究方法2018年1月至7月,德西综合专科医院开展了一项横断面比较研究,评估结核病患者的免疫血液学和生化变化。研究连续纳入了 164 名新确诊的肺结核患者和 80 名表面健康的对照组。变量以频率、百分比和均数(±SD)表示。为了比较各组或组内的平均±标准差,我们使用了独立样本 t 检验。P 值小于 0.05 即为统计学意义。结果与男性健康对照组相比,男性肺结核患者的平均绝对白细胞计数、中性粒细胞计数、淋巴细胞计数、血小板计数和全身免疫炎症明显偏高(分别为 P=0.001、P=0.011、P=0.021、P=0.001 和 P=0.018)。女性肺结核患者的平均血小板计数明显高于女性对照组(P=0.015)。然而,肺结核患者的平均红细胞计数、血红蛋白、血细胞比容和容积均明显低于男性(P<0.001)和女性健康对照组(分别为 P=0.022、0.015 和 0.001)。结核病患者出现贫血(23.8%)、白细胞异常(29.3%)、血小板增多(11.6%)和血小板减少(9.8%)。病例的平均丙氨酸氨基转移酶、总胆红素和葡萄糖水平明显高于健康对照组,但病例的平均总蛋白、碱性磷酸酶和总胆固醇水平明显低于健康对照组。结论在本研究中,肺结核患者的多项血液和生化指标都发生了显著变化。这表明,在对结核病进行鉴别诊断和评估治疗反应时,应监测并正确解释血液和生化指标。
{"title":"Immuno-Hematological and Biochemical Changes in Patients with Tuberculosis in Dessie Comprehensive Specialized Hospital, Dessie, Ethiopia","authors":"Angesom Gebreweld, Temesgen Fiseha, E. Kebede, Zemenu Tamir, Brhane Gebremariam, Fikadu Miruts, Haftay Haileslasie","doi":"10.2147/jbm.s445857","DOIUrl":"https://doi.org/10.2147/jbm.s445857","url":null,"abstract":"Background: Tuberculosis (TB) is a serious worldwide health issue, particularly in developing nations like Ethiopia. Patients with tuberculosis experience a range of hematological, immunological, and biochemical alterations. The purpose of this study was to evaluate immunological, hematological, and biochemical alterations of newly diagnosed TB patients at Dessie comprehensive specialized hospital, Dessie, Ethiopia. Methods: A comparative, cross-sectional study was carried out to evaluate the immuno-hematological and biochemical changes in patients with tuberculosis at Dessie comprehensive specialized hospital from January to July 2018. One hundred sixty-four (164) newly diagnosed TB patients, and 80 apparently healthy controls were included consecutively. The variables were expressed in frequency, percentage, and mean ± SD. To compare mean ± SD of the groups or within the groups, we used an independent sample t -test. Statistical significance was defined as a P value less than 0.05. Results: Male TB patients had significantly high mean absolute WBC count, neutrophil count, lymphocyte, platelet count, and systemic immune-inflammation compared with male healthy controls (P=0.001, P=0.011 P=0.021, P=0.001, and P=0.018, respectively). The mean platelet count of female TB patients was significantly higher than that of the female control group (P=0.015). However, mean RBC counts, Hgb, HCT, and MPV of TB patients were significantly lower than those of male (p<0.001) and female healthy controls (P=0.022, 0.015, and 0.001, respectively). The TB patients had developed anemia (23.8%), WBC abnormalities (29.3%), thrombocytosis (11.6%), and thrombocytopenia (9.8%). The cases had significantly higher mean alanine amino transferase, total bilirubin, and glucose level, but the mean total protein, alkaline phosphatase, and total cholesterol of cases were significantly lower than healthy control groups. Conclusion: TB patients in this study showed significant alterations in a number of hematological and biochemical profiles. This indicates that hematological and biochemical profiles should be monitored and properly interpreted for the differential diagnosis of tuberculosis and evaluation of response to treatment.","PeriodicalId":506923,"journal":{"name":"Journal of Blood Medicine","volume":"1140 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140273053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIF2-α Expression in CML Patients Receiving Hydroxyurea Prior to Imatinib That Achieved Major Molecular Response (MMR) versus in Those Not Achieving MMR 伊马替尼治疗前接受羟基脲治疗并获得主要分子反应(MMR)的 CML 患者与未获得主要分子反应的患者的 HIF2-α 表达比较
Pub Date : 2024-02-01 DOI: 10.2147/jbm.s436015
I. Rinaldi, Radinal Mauludi, Sri Jusman, R. Sinto, K. Harimurti
{"title":"HIF2-α Expression in CML Patients Receiving Hydroxyurea Prior to Imatinib That Achieved Major Molecular Response (MMR) versus in Those Not Achieving MMR","authors":"I. Rinaldi, Radinal Mauludi, Sri Jusman, R. Sinto, K. Harimurti","doi":"10.2147/jbm.s436015","DOIUrl":"https://doi.org/10.2147/jbm.s436015","url":null,"abstract":"","PeriodicalId":506923,"journal":{"name":"Journal of Blood Medicine","volume":"40 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139821884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIF2-α Expression in CML Patients Receiving Hydroxyurea Prior to Imatinib That Achieved Major Molecular Response (MMR) versus in Those Not Achieving MMR 伊马替尼治疗前接受羟基脲治疗并获得主要分子反应(MMR)的 CML 患者与未获得主要分子反应的患者的 HIF2-α 表达比较
Pub Date : 2024-02-01 DOI: 10.2147/jbm.s436015
I. Rinaldi, Radinal Mauludi, Sri Jusman, R. Sinto, K. Harimurti
{"title":"HIF2-α Expression in CML Patients Receiving Hydroxyurea Prior to Imatinib That Achieved Major Molecular Response (MMR) versus in Those Not Achieving MMR","authors":"I. Rinaldi, Radinal Mauludi, Sri Jusman, R. Sinto, K. Harimurti","doi":"10.2147/jbm.s436015","DOIUrl":"https://doi.org/10.2147/jbm.s436015","url":null,"abstract":"","PeriodicalId":506923,"journal":{"name":"Journal of Blood Medicine","volume":"21 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139881785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of Reference Intervals of Blood Parameters Among the Healthy Afghan Population 确定阿富汗健康人群血液参数的参考区间
Pub Date : 2024-02-01 DOI: 10.2147/jbm.s437594
Najia Sherzay, Z. Azimi, S. H. Sheikh Abdul Kadir, N. S. Mohd Nor
{"title":"Establishment of Reference Intervals of Blood Parameters Among the Healthy Afghan Population","authors":"Najia Sherzay, Z. Azimi, S. H. Sheikh Abdul Kadir, N. S. Mohd Nor","doi":"10.2147/jbm.s437594","DOIUrl":"https://doi.org/10.2147/jbm.s437594","url":null,"abstract":"","PeriodicalId":506923,"journal":{"name":"Journal of Blood Medicine","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139887489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of Reference Intervals of Blood Parameters Among the Healthy Afghan Population 确定阿富汗健康人群血液参数的参考区间
Pub Date : 2024-02-01 DOI: 10.2147/jbm.s437594
Najia Sherzay, Z. Azimi, S. H. Sheikh Abdul Kadir, N. S. Mohd Nor
{"title":"Establishment of Reference Intervals of Blood Parameters Among the Healthy Afghan Population","authors":"Najia Sherzay, Z. Azimi, S. H. Sheikh Abdul Kadir, N. S. Mohd Nor","doi":"10.2147/jbm.s437594","DOIUrl":"https://doi.org/10.2147/jbm.s437594","url":null,"abstract":"","PeriodicalId":506923,"journal":{"name":"Journal of Blood Medicine","volume":"21 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139827722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Blood Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1